Reports - Drug Screening Market
HealthcareDrug Screening Market
Drug Screening Market Trends, Growth & Innovations (2025–2035) by Services (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) by Type (Urine, Breath, Oral Fluid/Saliva, Hair, Other Samples (Blood & Sweat)) by End User Industry (Workplace, Laboratories, Criminal Justice, Hospitals) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Drug Screening Market - Segment Analysis
1. Overview
2. Global Drug Screening Market, 2020 - 2032 (USD Million)
3. Global Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. Global Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. Global Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
6. Global Drug Screening Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Drug Screening Market - Segment Analysis
1. Overview
2. North America Drug Screening Market, 2020 - 2032 (USD Million)
3. North America Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. North America Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. North America Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
Chapter 5 Europe Drug Screening Market - Segment Analysis
1. Overview
2. Europe Drug Screening Market, 2020 - 2032 (USD Million)
3. Europe Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. Europe Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. Europe Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
Chapter 6 Asia Pacific Drug Screening Market - Segment Analysis
1. Overview
2. Asia Pacific Drug Screening Market, 2020 - 2032 (USD Million)
3. Asia Pacific Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. Asia Pacific Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. Asia Pacific Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
Chapter 7 Latin America Drug Screening Market - Segment Analysis
1. Overview
2. Latin America Drug Screening Market, 2020 - 2032 (USD Million)
3. Latin America Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. Latin America Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. Latin America Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
Chapter 8 Middle East & Africa Drug Screening Market - Segment Analysis
1. Overview
2. Middle East & Africa Drug Screening Market, 2020 - 2032 (USD Million)
3. Middle East & Africa Drug Screening Market - by Services
3.1. By Consumables
3.2. By Urine Testing Devices
3.3. By Analytical
3.4. By Breathalyzer
3.5. By Chromatography
3.6. By Immunoassay
4. Middle East & Africa Drug Screening Market - by Type
4.1. By Urine, Breath
4.2. By Oral Fluid/Saliva
4.3. By Hair
4.4. By Other Samples (Blood & Sweat)
5. Middle East & Africa Drug Screening Market - by End User Industry
5.1. By Workplace
5.2. By Laboratories
5.3. By Criminal Justice
5.4. By Hospitals
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. LabCorp
2. Quest Diagnostics
3. Abbott Laboratories
4. OraSure Technologies
5. Alfa Scientific Designs
6. Thermo Fisher Scientific
7. Drägerwerk
8. LifeLoc
9. MPD Inc.
10. Omega Laboratories
11. Premier Biotech
12. Psychemedics
13. Roche
14. Shimadzu
15. and Siemens Healthineers.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By